Drugs Made In America Acquisition (DMAAR) Treasury Shares (2025)

Drugs Made In America Acquisition (DMAAR) posted Treasury Shares of $23.0 million for Q4 2025, little changed on a QoQ basis from $23.0 million in Q3 2025.

Drugs Made In America Acquisition (DMAAR) Treasury Shares (2025) Analysis & Trends

Drugs Made In America Acquisition's Treasury Shares history runs 1 years deep, the most recent figure standing at $23.0 million for Q4 2025.

  • Quarterly Treasury Shares changed N/A year-over-year to $23.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $23.0 million (changed N/A YoY) and the FY2025 annual result came in at $23.0 million, changed N/A from the prior year.
  • Treasury Shares was $23.0 million for Q4 2025 at Drugs Made In America Acquisition, roughly flat from $23.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $23.0 million in Q1 2025 and bottomed at $23.0 million in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 SIM Acquisition Corp. I 314.52 Mn 314.52 Mn - -
2 Thayer Ventures Acquisition 208.29 Mn 208.29 Mn - 20.13 Mn
3 Newbury Street II Acquisition 185.26 Mn 185.26 Mn - 17.25 Mn
4 Dynamix 178.78 Mn 178.78 Mn - 16.60 Mn
5 Hallmark Venture 103.01 Mn 102.76 Mn - 115,752.00
6 Voyager Acquisition 99.58 Mn 99.45 Mn - -
7 Gores Holdings X 95.80 Mn 95.37 Mn - -
8 Archimedes Tech SPAC Partners 89.88 Mn 89.88 Mn - 23.00 Mn
9 Cohen Circle Acquisition 80.05 Mn 80.05 Mn - 25.30 Mn
10 Drugs Made In America Acquisition 1.46 Mn 1.46 Mn - 23.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 23.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 23.00 Mn
Sep 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Mar 31, 2025 23.00 Mn
Mar 31, 2025 23.00 Mn